PUBLISHER: Grand View Research | PRODUCT CODE: 1511843
PUBLISHER: Grand View Research | PRODUCT CODE: 1511843
The global flow diverters market size is expected to reach USD 722.59 million by 2030, registering a CAGR of 13.29% from 2024 to 2030, according to a new report by Grand View Research, Inc. Rising awareness about minimally invasive treatment option, regulatory approvals, collaboration and partnerships, along with growing research activity in the field of brain aneurysm treatment are driving the market growth.
Increasing number of patients suffering from hypertension significantly increases the risk of brain aneurysm. For instance, as per the Barcelona Institute for Global Health (ISGlobal) in 2022, Hypertension is one of the top causes of death worldwide, accounting for 12.8% of all fatalities each year. Furthermore, as per the WHO in 2023, worldwide, an estimated 1.28 billion persons aged 30-79 years have hypertension, with the majority (two-thirds) living in middle and low income nations. These factors are expected to increase the demand in the coming years.
Several initiatives launched by the government of various countries to improve public awareness and treatment related to cerebral aneurysm are anticipated to spur the demand in near future. For instance, the Brain Aneurysm Foundation of Canada works toward spreading awareness and educating about brain aneurysm. This programs include and social media campaigns early access to monthly educational webinars for highlighting the prevalence of brain aneurysm.
Companies are developing and launching technologically advanced products for attracting more customers in the market. For instance, in January 2020, MicroVention, Inc. (a subsidiary of Terumo Corporation) has gained FDA Premarket Clearance for their FRED, which is used to treat cerebral aneurysms. It makes use of a self-expanding, woven nitinol mesh to reroute blood flow and facilitate aneurysm closure which is expected to boost the demand in the near future.